Statement on Drug Pricing Provisions Included in “Inflation Reduction Act”
07/05/2022 | Press release | Distributed by Public on 07/05/2022 15:52
Please select the service you want to use:
Smartlinks | La Jolla Pharmaceutical Company | News | Health | Local News | Finance | Security Markets | Derivative Securities | Security Markets | Company News | Shareholders | Buyback, Treasury Shares and Liquidity Agreements | Internal Dealings | Public Companies | Biotechnology and Medical Research Companies | Börse Frankfurt | Börse Düsseldorf | Börse Stuttgart | BX Swiss | NYSE American | NYSE ARCA Equities | Nasdaq Capital Market | BZX Exchange | BYX Exchange | EDGA Exchange | EDGX Exchange | NYSE National | Nasdaq BX | Nasdaq PSX | NYSE Chicago
Back
Copyright ©2006-2022 Public Technologies Inc. | Privacy Policy | Terms of Use | Contact